Price Chart

Profile

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
URL http://www.inovio.com
Investor Relations URL https://ir.inovio.com
HQ State/Province Pennsylvania
Sector Health Care
Industry Biotechnology
Next Earnings Release May. 13, 2026 (est.)
Last Earnings Release Mar. 12, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
URL http://www.inovio.com
Investor Relations URL https://ir.inovio.com
HQ State/Province Pennsylvania
Sector Health Care
Industry Biotechnology
Next Earnings Release May. 13, 2026 (est.)
Last Earnings Release Mar. 12, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A